Research Progress on the Pharmacological Effects and Clinical Application of Erigeron Brevicapas in the Treatment of Malignant Tumors

Authors

  • Kun Chen Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Yanli Zhao Affiliated Hospital of Shannxi University of Chinese Medicine, Xianyang 712000, Shaanxi, China
  • Ju Ou Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2025.07(01).22

Keywords:

Breviscapus, Tumor, Pharmacology, Clinical effect

Abstract

To investigate the pharmacological action and clinical application of Breviscapus and its derivatives in the treatment of malignant tumors, and to provide reference for further research and clinical application of breviscapus and its derivatives in the treatment of malignant tumors. In China National Knowledge Network (CNKI), WanfangDate Data Knowledge Platform and PubMed database with "Breviscapine", "Pharmacology", "Oncology", "Breviscapine", "scutellain", "Pharmacology", "Tumor" and so on as keywords, Relevant literatures published from May 2000 to August 2022 were retrieved to sort out and summarize the pharmacological effects and clinical applications of calendula breviscapus in tumor therapy.

References

Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249.

Cao Maomao; Chen Wanqing (N.Interpretation on the global cancer statistics of GLOBOCAN 2020[J]. Chinese Journal of the Frontiers of Medical Science (Electronic Version), 2021, 13(3):63-69.

ZHANG Binglei, ZHANG Zhiming, SONG Zhongyang, et al. Discussion on TCM prevention and treatment of malignant tumor based on the idea of "Removing bad accumulation by strengthening healthy energy" [J]. Clinical Journal of Chinese Medicine, 2022, 14(18): 130-132+143.

SHARMA; NEELESH; SAMARAKOON; KALPA W.; GYAWALI; RAJENDRA, et al. Evaluation of the Antioxidant, Anti-Inflammatory, and Anticancer Activities of Euphorbia hirta Ethanolic Extract[J]. Molecules, 2014, 19(9):14567-14581.

GE Wen-xiu; LUO Yun; XIE Xue-heng; SUN Gui-bo; YU Miao; SUN Xiao-bo. Research Progress on Pharmacological Mechanisms of Scutellarin[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2020, 26(22):193-200.

Shi Senlin; Xu Lianying; et al. Study on physicochemical properties and influence factors on stability of breviscapine [J]. China Journal of Chinese Materia Medica, 2009, 34(7):843-847.

Liu Y, Wen PH, Zhang XX, et al. Breviscapine ameliorates CCl4 induced liver inj ury in mice through inhibiting inflammatory apoptotic response and ROS generation[J]. Int J Mol Med, 2018, 42(2):755-768.

Wang Q, Wang Q, Wang SF, et al. Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-smal-l cell lung cancer: A systematic review and Meta-analysis [J]. Current Oncology, 20 1 7, 24 (4):2 6 9-2 7 6.

Fan Hua, Lin Peng, Kang Qiang, et al. Metabolism and Pharmacological Mechanisms of Active Ingredients in Erigeron breviscapus [J]. Current drug metabolism, 2021, 22(1):24-39.

EGHBALIFERIZ, SAMIRA, TALEGHANI, AKRAM, TAYARANI-NAJARAN, ZAHRA. Scutellaria: Debates on the anticancer property[J]. Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie, 2018, 1051299-1310.

WEI Weitian;CHEN Sheng;WANG Liang;ZENG Jian. Breviscapine induced the apoptosis of non-small cell lung cancer A549 cells[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6):618-624.

LIU Ting; LI Yang; SHI Zhihong. Effects of breviscapine on proliferation and apoptosis of non-small cell lung cancer A549 cells[J]. Shaanxi Journal of Traditional Chinese Medicine, 2021, 42(10):1363-1366.

Tongtong LI, Manru LIU, Dongsheng PEI. Friend or foe, the role of EGR-1 in cancer[J]. Medical oncology., 2020, 37(1):7.

Han J, Wang P, Xia X, Zhang L, Zhang H, Huang Y, Li X, Zhao W, Zhang L. EGR1 promoted anticancer effects of Scutellarin via regulating LINC00857/miR-150-5p/c-Myc in osteosarcoma. [J] Cell Mol Med. 2021 Sep;25(17):8479-8489.

Ye J, Gao M, Guo X, Zhang H, Jiang F. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway. Biomed Pharmacother. 2020 Jul;127:110223.

Wu Xianchuang. Research on the Anti-fibrotic and Anti-tumor Effects of Scutellarin[D]. Henan: Henan University, 2010.

Li Zhonghai; Wang Jingze. Vascular Endothelial Growth Factor-C and Tumour Metastasis[J]. Chemistry of Life, 2003, 23(4):300-302.

KIMURA, Y., SUMIYOSHI, M.. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis [J]. Phytomedicine: international journal of phytotherapy and phytopharmacology, 2013, 20(3/4):328-336.

LI, JIANKUN, WANG, HAIRONG, SHI, XIAOWEI, et al. Anti-proliferative and anti-migratory effects of Scutellaria strigillosa Hemsley extracts against vascular smooth muscle cells[J]. Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs, 2019, 235155-163.

Yu Lijuan; Lin Haihong; Du Gangjun;et al. Preventive effect of breviscapine on metastasis and recurrence of breast cancer after the tumor removal in mice[J]. Journal of Henan University: Medical Science, 2009, 28(3): 182-184.

Zhao Juan. Observation on the Efficacy of Hyperbaric Oxygen Liquid and Erigeron brevicapas Injection in the Treatment of Acute Cerebral Infarction[J]. Chinese Journal of Practical Nervous Diseases, 2006, 9(5):83-83.

He Lin; He Furong. The Difference and Similar Regard of Tumor's Antiagiogenic Therapy between East-west Medicines[J]. Medicine & Philosophy(B), 2009, 30(10):72-74.

Diao X, Yang D, Chen Y, Liu W. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase. Biosci Rep. 2019 Apr 9;39(4):BSR20181692.

LIU Wenbin; CAO Guangwen. Cancer evolution-development: novel theory based on studies of inflammation-cancer transformation[J]. Chinese Journal of Cancer Biotherapy, 2017, 24(2):103-111.

Shen Zhengjie; Cheng Haibo; Shen Weixing; Wu Mianhua. Correlation between tumor inflammatory microenvironment and “cancerous toxin” pathogenesis [J]. Journal of Beijing University of Traditional Chinese Medicine, 2015, 38(1):14-17.

Li zhaofei. Research on the Protective Effect and Mechanism of Scutellarin on Vascular Endothelial Cell Injury[D]. Guangxi University of Chinese Medicine, 2016.

BAI Rujun, LIU Jun, ZHOU Youli. Effects of Breviscapine on Wnt/β-catenin Signaling Pathway and Inflammatory Mediators in Rats with Vascular Endothelial Cell Injury[J/OL]. World Chinese Medicine1-13[2022-11-23]. http://kns.cnki.net/kcms/detail/11.5529.R.20221030.1720.004.html

Li Y, Li S, Li D. Breviscapine Alleviates Cognitive Impairments Induced by Transient Cerebral Ischemia/Reperfusion through Its Anti-Inflammatory and Anti-Oxidant Properties in a Rat Model. ACS Chem Neurosci. 2020 Dec 16;11(24):4489-4498.

Liu Yiman, Yang Shenshen, Wang Kailong, Lu Jia, Bao Xiaomei, Wang Rui, Qiu Yuling, Wang Tao, Yu Haiyang. Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products. [J]. Cell proliferation, 2020, 53(10).

Zhang Yan. Research on the Anti-inflammatory and Immunoregulatory Effects of Baicalin and Baicalein[D]. Shanghai: Second Military Medical University, 2012.

Dou J, Wang Z, Ma L, Peng B, Mao K, Li C, Su M, Zhou C, Peng G. Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget. 2018 Jan 8;9(28):20089-20102.

Elalamy I, Verdy E, Gerotziafas G, et a1. Pathogenesis ofvenous thromboemloolic disease in cancer[J]. Pathol Biol, 2008, 56(4): 184.

Fernandes CJ, Morinaga LTK, Alves JL Jr, Castro MA, Calderaro D, Jardim CVP, Souza R. Cancer-associated thrombosis: the when, how and why. Eur Respir Rev. 2019 Mar 27;28(151):180119.

LI Xiao-xiao; MA Yun-fei; LI Guang-da; WANG Xiao-min; ZHANG Yi. Pathogenesis of hypercoagulable state in patients with malignant tumor and its treatment by TCM and western medicine[J].World Journal of Integrated Traditional and Western Medicine, 2019, 14(11):1619-1623.

Gussoni G, Frasson S, La Regina M, et al. Three - month mortality rate and clinical predictors in patients with venousthromboembolism and cancer. Findings from the RIETE registry[J]. Thromb Res, 2013, 131(1):24-30.

Wang Yuhui; Tong Mengli. Clinical observation of chronic renal with blood clotting and blood-lipid abnormality treated with Herba Erigerontis [J]. Acta Chinese Medicine and Pharmacology, 2003, 31(3):4-5.

Ren Minshan; Huang Shanshan; Guo Wenxiu. Effects and mechanisms of erigeron injection in improving the hypercoagulable state of malignant tumors[J]. Journal of Clinical Medicine in Practice, 2013, 17(14):62-64.

Wu Jiping; Li Shihui. Treatment of 39 cases of gastrointestinal tumors with blood-activating and stasis-removing method combined with chemotherapy. [J]. Shaanxi Journal of Traditional Chinese Medicine, 1999, (2):52.

QUINN T. OSTROM, LUC BAUCHET, FAITH G. DAVIS, et al. The epidemiology of glioma in adults: a 'state of the science' review[J]. Neuro-oncology, 2014, 16(7):896-913.

Zhangrui; Jin Hua; Lv Zhonghua, et al. Advances in Glioma Surgery and Adjunctive Techniques[J]. Journal of Modern Oncology, 2014, 22(4):937-941.

Wu Youran; Zhou Chunli; Wang Yong. The effect of propofol combined with remifentanil target-controlled infusion and breviscapine injection on cerebral protection and emergence quality in patients undergoing brain glioma resection surgery. [J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2018, 27(29):3290-3293.

Xu Xiaomei. Study on the Effect of Scutellarin in Treating Cerebral Vasospasm after Brain Tumor Surgery[J]. Integrated Chinese-Western Medicine Journal of Cardiovascular Diseases, 2016, 4(21):127.

TONG HAN, YAN WANG, MINGYING WANG, et al. Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway[J]. European Journal of Medicinal Chemistry: Chimie Therapeutique, 2018, 158493-158501.

Wang JN, Tan JY, Luo JH, et al., 2017. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy. J Nanobiotechnol, 15: 18.

Downloads

Published

2025-01-31

How to Cite

Chen, K., Zhao, Y., & Ou, J. (2025). Research Progress on the Pharmacological Effects and Clinical Application of Erigeron Brevicapas in the Treatment of Malignant Tumors. Journal of Contemporary Medical Practice, 7(1), 111–116. https://doi.org/10.53469/jcmp.2025.07(01).22